| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.4 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.043 | 0.4 |